- Home
- EXLS vs CRL Comparison
EXLS vs CRL Comparison
Compare EXLS & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXLS
- CRL
- Stock Information
- Founded
- EXLS 1999
- CRL 1947
- Country
- EXLS United States
- CRL United States
- Employees
- EXLS N/A
- CRL N/A
- Industry
- EXLS Business Services
- CRL Biotechnology: Commercial Physical & Biological Resarch
- Sector
- EXLS Consumer Discretionary
- CRL Health Care
- Exchange
- EXLS Nasdaq
- CRL Nasdaq
- Market Cap
- EXLS 7.0B
- CRL 7.1B
- IPO Year
- EXLS 2006
- CRL 2000
- Fundamental
- Price
- EXLS $44.65
- CRL $157.45
- Analyst Decision
- EXLS Strong Buy
- CRL Hold
- Analyst Count
- EXLS 7
- CRL 14
- Target Price
- EXLS $49.57
- CRL $186.38
- AVG Volume (30 Days)
- EXLS 3.1M
- CRL 865.4K
- Earning Date
- EXLS 07-31-2025
- CRL 08-06-2025
- Dividend Yield
- EXLS N/A
- CRL N/A
- EPS Growth
- EXLS 21.21
- CRL N/A
- EPS
- EXLS 1.32
- CRL N/A
- Revenue
- EXLS $1,902,884,000.00
- CRL $4,022,597,000.00
- Revenue This Year
- EXLS $14.18
- CRL N/A
- Revenue Next Year
- EXLS $11.53
- CRL $2.49
- P/E Ratio
- EXLS $33.77
- CRL N/A
- Revenue Growth
- EXLS 14.18
- CRL N/A
- 52 Week Low
- EXLS $31.02
- CRL $91.86
- 52 Week High
- EXLS $52.43
- CRL $254.15
- Technical
- Relative Strength Index (RSI)
- EXLS 44.50
- CRL 68.41
- Support Level
- EXLS $43.58
- CRL $148.41
- Resistance Level
- EXLS $45.55
- CRL $160.40
- Average True Range (ATR)
- EXLS 1.28
- CRL 4.82
- MACD
- EXLS -0.20
- CRL 0.32
- Stochastic Oscillator
- EXLS 28.88
- CRL 82.99
About EXLS ExlService Holdings Inc.
ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.